Article Link: Ipsen Announces FDA approval of Dysport (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults &#...
Adamis Pharmaceuticals Receives FDA Approval for Symjepi (epinephrine) Pre-Filled Syringe
Article Link: Adamis Pharmaceuticals Receives FDA Approval for Symjepi (epinephrine) Pre-Filled Syringe Source: FDA New Dru...
FDA Approves Gleolan (aminolevulinic acid hydrochloride) as an Optical Imaging Agent in Patients with Gliomas
Article Link: FDA Approves Gleolan (aminolevulinic acid hydrochloride) as an Optical Imaging Agent in Patients with Gliomas ...
FDA Approves Two-Month Aristada for Treatment of Schizophrenia
Article Link: FDA Approves Two-Month Aristada for Treatment of Schizophrenia Source: FDA New Drug Approvals
Nicox Receives FDA Approval of Zerviate (cetirizine ophthalmic solution) 0.24%
Article Link: Nicox Receives FDA Approval of Zerviate (cetirizine ophthalmic solution) 0.24% Source: FDA New Drug Approvals
Merck Receives FDA Approval of Isentress HD (raltegravir), a New Once-Daily Option for the Combination Treatment of HIV-1 Infection in Appropriate Patients
Article Link: Merck Receives FDA Approval of Isentress HD (raltegravir), a New Once-Daily Option for the Combination Treatment of HIV-1 Infection in A...
FDA Approves Keytruda (pembrolizumab) as First Cancer Treatment for any Solid Tumor with a Specific Genetic Feature
Article Link: FDA Approves Keytruda (pembrolizumab) as First Cancer Treatment for any Solid Tumor with a Specific Genetic Feature ...
Sanofi and Regeneron Announce FDA Approval of Kevzara (sarilumab) for Rheumatoid Arthritis
Article Link: Sanofi and Regeneron Announce FDA Approval of Kevzara (sarilumab) for Rheumatoid Arthritis Source: FDA New Dr...
FDA Approves Actemra (tocilizumab) Subcutaneous Injection for Giant Cell Arteritis
Article Link: FDA Approves Actemra (tocilizumab) Subcutaneous Injection for Giant Cell Arteritis Source: FDA New Drug Appro...
FDA Approves Merck’s Keytruda (pembrolizumab) for Certain Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Article Link: FDA Approves Merck’s Keytruda (pembrolizumab) for Certain Patients with Locally Advanced or Metastatic Urothelial Carcinoma ...
